AbbVie Inc. 10-Q filing
Filed 2026-05-08 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001551152-26-000017
- Form type
- 10-Q
- CIK
- 0001551152
- Primary document
- https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/abbv-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AbbVie Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $15.0B | - | - |
| Cost Of Revenue | $4.2B | - | - |
| Operating Income | $4.0B | - | - |
| Net Income | $695.0M | - | - |
| Eps Basic | 0.39 | - | - |
| Eps Diluted | 0.39 | - | - |
| Cash And Equivalents | $9.4B | - | - |
| Total Assets | $136.5B | - | - |
| Shareholders Equity | $-6.7B | - | - |
| Operating Cash Flow | $3.8B | - | - |
| Capital Expenditures | $265.0M | - | - |